References
Khayachi A, Gwizdek C, Poupon G, Alcor D, Chafai M, Casse F, et al. Sumoylation regulates FMRP-mediated dendritic spine elimination and maturation. Nat Commun 2018, 9: 757.
Narayanan U, Nalavadi V, Nakamoto M, Pallas DC, Ceman S, Bassell GJ, et al. FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci 2007, 27: 14349–14357.
Elrouby N. Analysis of small ubiquitin-like modifier (sumo) targets reflects the essential nature of protein SUMOylation and provides insight to elucidate the role of SUMO in plant development. Plant Physiol 2015, 169: 1006–1017.
Rocca DL, Wilkinson KA, Henley JM. SUMOylation of FOXP1 regulates transcriptional repression via CtBP1 to drive dendritic morphogenesis. Sci Rep 2017, 7: 877.
Girach F, Craig TJ, Rocca DL, Henley JM. RIM1alpha SUMOylation is required for fast synaptic vesicle exocytosis. Cell Rep 2013, 5: 1294–1301.
Shalizi A, Bilimoria PM, Stegmuller J, Gaudilliere B, Yang Y, Shuai K, et al. PIASx is a MEF2 SUMO E3 ligase that promotes postsynaptic dendritic morphogenesis. J Neurosci 2007, 27: 10037–10046.
Cheng J, Huang M, Zhu Y, Xin YJ, Zhao YK, Huang J, et al. SUMOylation of MeCP2 is essential for transcriptional repression and hippocampal synapse development. J Neurochem 2014, 128: 798–806.
Usui N, Co M, Harper M, Rieger MA, Dougherty JD, Konopka G. Sumoylation of FOXP2 regulates motor function and vocal communication through Purkinje cell development. Biol Psychiatry 2017, 81: 220–230.
Craig TJ, Anderson D, Evans AJ, Girach F, Henley JM. SUMOylation of Syntaxin1A regulates presynaptic endocytosis. Sci Rep 2015, 5: 17669.
Liu F, Ni JJ, Sun FY. Expression of phospho-MeCP2s in the developing rat brain and function of postnatal MeCP2 in cerebellar neural cell development. Neurosci Bull 2017, 33: 1–16.
Tai DJ, Liu YC, Hsu WL, Ma YL, Cheng SJ, Liu SY, et al. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome. Nat Commun 2016, 7: 10552.
Dorval V, Fraser PE. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J Biol Chem 2006, 281: 9919–9924.
Hoppe JB, Rattray M, Tu H, Salbego CG, Cimarosti H. SUMO-1 conjugation blocks beta-amyloid-induced astrocyte reactivity. Neurosci Lett 2013, 546: 51–56.
Myrick LK, Nakamoto-Kinoshita M, Lindor NM, Kirmani S, Cheng X, Warren ST. Fragile X syndrome due to a missense mutation. Eur J Hum Genet 2014, 22: 1185–1189.
Bartley CM, O’Keefe RA, Blice-Baum A, Mihailescu MR, Gong X, Miyares L, et al. Mammalian FMRP S499 is phosphorylated by CK2 and promotes secondary phosphorylation of FMRP. eNeuro 2016, 3.
Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, et al. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet 2009, 46: 266–271.
Acknowledgements
This highlight was supported by the National Natural Science Foundation of China (81503074).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Tang, M., Lu, L., Xie, F. et al. SUMOylation of Fragile X Mental Retardation Protein: A Critical Mechanism of FMRP-Mediated Neuronal Function. Neurosci. Bull. 34, 1100–1102 (2018). https://doi.org/10.1007/s12264-018-0290-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12264-018-0290-y